Supriya Lifescience Limited — Updates, 28-05-2026: Press Release
28-05-2026 | 09:13 am
28-05-2026 | 09:13 am
Supriya Lifescience posted strong Q4 revenue +50% to ₹276.53 Cr & FY26 revenue +19% to ₹827.87 Cr. Growth fueled by the anesthetic segment, 74% capacity utilization, new product commercialization, and strategic manufacturing expansions, enhancing global reach.
No comments yet. Be the first to comment!
